While much of the nation's attention is focused on new medical benefits under the healthcare overhaul signed into law by President Obama, mental health advocates are stepping up attention to the Mental Health Parity and Addiction Equity Act, which began providing benefits to millions of patients with addictions, depression and other mental illness. The act was designed to put mental health services on equal footing with other medical services. Dr. Carolyn Robinowitz, past president of the American Psychiatric Association, tells host Bruce Japsen about this law and its importance for physicians and their patients.
Review of the Mental Health Parity and Addiction Equity Act

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
While much of the nation's attention is focused on new medical benefits under the healthcare overhaul signed into law by President Obama, mental health advocates are stepping up attention to the Mental Health Parity and Addiction Equity Act, which began providing benefits to millions of patients with addictions, depression and other mental illness. The act was designed to put mental health services on equal footing with other medical services. Dr. Carolyn Robinowitz, past president of the American Psychiatric Association, tells host Bruce Japsen about this law and its importance for physicians and their patients.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
Combination Therapies: Approaches for Getting to Goal Quickly vs Titration Over Time
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
Partnering with Patients: Building Effective Communication and Support in HF Care
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?